Beijing Anzhen Hospital

Company snapshot

Beijing Anzhen Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Heart Valve Diseases, Angina, Stable. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources.

• 2 active pipeline program(s) linked via ClinicalTrials.gov.
• 2 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Beijing Anzhen Hospital. Not investment advice.

• What is Beijing Anzhen Hospital?

  Beijing Anzhen Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Heart Valve Diseases, Angina, Stable. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalT

• Is Beijing Anzhen Hospital publicly traded?

  Beijing Anzhen Hospital appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Beijing Anzhen Hospital develop or market?

  We link 1 drug profile(s) where Beijing Anzhen Hospital is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/beijing-anzhen-hospital#company-drugs.

• What are the latest developments for Beijing Anzhen Hospital?

  In the last 12 months our linked public records show 2 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Beijing Anzhen Hospital focus on?

  Beijing Anzhen Hospital focuses on Heart Valve Diseases, Angina, Stable based on our analysis of their pipeline programs and drug development activities.